145 related articles for article (PubMed ID: 36043408)
1. Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study.
Hadi N; Seifati SM; Nateghi B; Ravaghi P; Khosravian F; Namazi F; Fotouhi Firouzabad M; Shaygannejad V; Salehi M
Cell J; 2022 Jul; 24(7):403-409. PubMed ID: 36043408
[TBL] [Abstract][Full Text] [Related]
2. MiR-9-5p and miR-106a-5p dysregulated in CD4
Majd M; Hosseini A; Ghaedi K; Kiani-Esfahani A; Tanhaei S; Shiralian-Esfahani H; Rahnamaee SY; Mowla SJ; Nasr-Esfahani MH
Iran J Basic Med Sci; 2018 Mar; 21(3):277-283. PubMed ID: 29511494
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
[TBL] [Abstract][Full Text] [Related]
4. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
[TBL] [Abstract][Full Text] [Related]
5. miR-574, miR-499, miR-125b, miR-106a, and miR-9 potentially target TGFBR-1 and TGFBR-2 genes involving in inflammatory response pathway: Potential novel biomarkers for chronic lymphocytic leukemia.
Hadi N; Namazi F; Ketabchi F; Khosravian F; Nateghi B; Talebi A; Baghi M; Mianesaz H; Zare F; Salehi M
Pathol Res Pract; 2022 Oct; 238():154077. PubMed ID: 36037658
[TBL] [Abstract][Full Text] [Related]
6. Identification of hsa-miR-106a-5p as an impact agent on promotion of multiple sclerosis using multi-step data analysis.
Rahimirad S; Navaderi M; Alaei S; Sanati MH
Neurol Sci; 2021 Sep; 42(9):3791-3799. PubMed ID: 33452935
[TBL] [Abstract][Full Text] [Related]
7. Identification of Potential Biomarkers in the Peripheral Blood Mononuclear Cells of Relapsing-Remitting Multiple Sclerosis Patients.
Golabi M; Fathi F; Samadi M; Hesamian MS; Eskandari N
Inflammation; 2022 Aug; 45(4):1815-1828. PubMed ID: 35347537
[TBL] [Abstract][Full Text] [Related]
8. Transcription Factor Specificity Protein 1 Regulates Inflammation and Fibrin Deposition in Nasal Polyps Via the Regulation of microRNA-125b and the Wnt/β-catenin Signaling Pathway.
Song L; Wang X; Qu X; Lv C
Inflammation; 2022 Jun; 45(3):1118-1132. PubMed ID: 34988755
[TBL] [Abstract][Full Text] [Related]
9. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML
J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs from
Baulina N; Osmak G; Kiselev I; Popova E; Boyko A; Kulakova O; Favorova O
Cells; 2019 Feb; 8(2):. PubMed ID: 30743997
[TBL] [Abstract][Full Text] [Related]
11. Swimming Impacts on Pancreatic Inflammatory Cytokines, miR-146a and NF-кB Expression Levels in Type-2 Diabetic Rats.
Alipour MR; Yousefzade N; Bavil FM; Naderi R; Ghiasi R
Curr Diabetes Rev; 2020; 16(8):889-894. PubMed ID: 31733638
[TBL] [Abstract][Full Text] [Related]
12. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
[No Abstract] [Full Text] [Related]
13. Increased expression of mir-301a in PBMCs of patients with relapsing-remitting multiple sclerosis is associated with reduced NKRF and PIAS3 expression levels and disease activity.
Tavakolpour V; Shokri G; Naser Moghadasi A; Mozafari Nahavandi P; Hashemi M; Kouhkan F
J Neuroimmunol; 2018 Dec; 325():79-86. PubMed ID: 30316680
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin suppresses LPS-induced expression of HMGB1, microRNA 155, 146, and TLR4/MyD88/NF-кB pathway in RAW264.7 cells.
Nemati M; Akseh S; Amiri M; Reza Nejabati H; Jodati A; Fathi Maroufi N; Faridvand Y; Nouri M
Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):153-159. PubMed ID: 33435756
[TBL] [Abstract][Full Text] [Related]
17. miR-106a Is Downregulated in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B and Associated with Enhanced Levels of Interleukin-8.
Hong Z; Hong H; Liu J; Zheng X; Huang M; Li C; Xia J
Mediators Inflamm; 2015; 2015():629862. PubMed ID: 26265888
[TBL] [Abstract][Full Text] [Related]
18. MiR-20a lowers chemosensitivity of liver cancer Huh-7 cells via regulating NF-кB expression.
Yang BM; Zhao JR; Huo TT; Zhang ML; Wu XH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11569-11577. PubMed ID: 33275223
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Expression Levels of miR-29b-3p and miR-326 in T Helper-1 and T Helper-17 Cells Isolated from Responsive and Non-responsive Relapsing-remitting Multiple Sclerosis Patients Treated with Interferon-beta.
Karimi L; Eskandari N; Shaygannejad V; Zare N; Andalib A; Khanahmad H; Mirmosayyeb O
Iran J Allergy Asthma Immunol; 2020 Aug; 19(4):416-425. PubMed ID: 33463108
[TBL] [Abstract][Full Text] [Related]
20. [Anti-inflammation effect of moxibustion for rats with diarrhea-predominant irritable bowel syndrome based on multiple miRNAs regulating NF-κB signal pathway].
Zhu SS; Wang JJ; Zou L; Chen JY; Li KW; Liao LM; Ruan JR; Li N; Chu HR
Zhongguo Zhen Jiu; 2022 Jun; 42(6):654-62. PubMed ID: 35712950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
